C. Langridge

2.2k total citations
29 papers, 1.5k citations indexed

About

C. Langridge is a scholar working on General Health Professions, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, C. Langridge has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in General Health Professions, 11 papers in Oncology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in C. Langridge's work include Patient-Provider Communication in Healthcare (11 papers), Ethics in Clinical Research (6 papers) and Breast Cancer Treatment Studies (6 papers). C. Langridge is often cited by papers focused on Patient-Provider Communication in Healthcare (11 papers), Ethics in Clinical Research (6 papers) and Breast Cancer Treatment Studies (6 papers). C. Langridge collaborates with scholars based in United Kingdom, Australia and Mexico. C. Langridge's co-authors include Lesley Fallowfield, Valerie Jenkins, Susan Catt, Anna Cox, Ivonne Solis‐Trapala, Leigh Johnson, Robert E. Mansel, Robert G. Newcombe, Mark Kissin and Anne Fleissig and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

C. Langridge

29 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Langridge United Kingdom 18 535 437 406 392 243 29 1.5k
Lauren P. Wallner United States 28 656 1.2× 225 0.5× 283 0.7× 300 0.8× 268 1.1× 130 2.0k
Johan Ahlgren Sweden 23 1.0k 1.9× 281 0.6× 461 1.1× 148 0.4× 151 0.6× 68 1.7k
Elissa Bantug United States 15 813 1.5× 227 0.5× 357 0.9× 259 0.7× 91 0.4× 23 1.5k
Paul Craft Australia 23 653 1.2× 295 0.7× 377 0.9× 169 0.4× 236 1.0× 43 1.6k
Ute‐Susann Albert Germany 20 689 1.3× 163 0.4× 381 0.9× 179 0.5× 82 0.3× 55 1.5k
Theresa Shao United States 12 764 1.4× 250 0.6× 384 0.9× 143 0.4× 89 0.4× 30 1.8k
Ana F. Best United States 17 302 0.6× 148 0.3× 192 0.5× 198 0.5× 224 0.9× 44 1.5k
Harvey Schipper Canada 14 888 1.7× 328 0.8× 143 0.4× 224 0.6× 202 0.8× 34 1.7k
Susan Catt United Kingdom 15 606 1.1× 631 1.4× 91 0.2× 491 1.3× 120 0.5× 29 1.6k
Rebecca Cowens-Alvarado United States 8 1.5k 2.8× 347 0.8× 277 0.7× 141 0.4× 150 0.6× 10 2.0k

Countries citing papers authored by C. Langridge

Since Specialization
Citations

This map shows the geographic impact of C. Langridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Langridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Langridge more than expected).

Fields of papers citing papers by C. Langridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Langridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Langridge. The network helps show where C. Langridge may publish in the future.

Co-authorship network of co-authors of C. Langridge

This figure shows the co-authorship network connecting the top 25 collaborators of C. Langridge. A scholar is included among the top collaborators of C. Langridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Langridge. C. Langridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fallowfield, Lesley, Ivonne Solis‐Trapala, Usha Menon, et al.. (2017). The effect of ovarian cancer screening on sexual activity and functioning: results from the UK collaborative trial of ovarian cancer screening RCT. British Journal of Cancer. 116(8). 1111–1117. 7 indexed citations
2.
Jenkins, Valerie, Lesley Fallowfield, C. Langridge, et al.. (2015). Psychosocial Factors Associated With Withdrawal From the United Kingdom Collaborative Trial of Ovarian Cancer Screening After 1 Episode of Repeat Screening. International Journal of Gynecological Cancer. 25(8). 1519–1525. 11 indexed citations
3.
Fallowfield, Lesley, et al.. (2015). Implications of subcutaneous or intravenous delivery of trastuzumab; further insight from patient interviews in the PrefHer study. The Breast. 24(2). 166–170. 25 indexed citations
4.
Jenkins, Valerie, Vernon T. Farewell, Daniel Farewell, et al.. (2013). Drivers and barriers to patient participation in RCTs. British Journal of Cancer. 108(7). 1402–1407. 67 indexed citations
5.
Jenkins, Valerie, Daniel Farewell, Vernon T. Farewell, et al.. (2013). Teams Talking Trials: Results of an RCT to improve the communication of cancer teams about treatment trials. Contemporary Clinical Trials. 35(1). 43–51. 17 indexed citations
6.
Ring, Alistair, Helena Harder, C. Langridge, Rachel Ballinger, & Lesley Fallowfield. (2013). Adjuvant chemotherapy in elderly women with breast cancer (AChEW): an observational study identifying MDT perceptions and barriers to decision making. Annals of Oncology. 24(5). 1211–1219. 30 indexed citations
7.
Fallowfield, Lesley, C. Langridge, & Valerie Jenkins. (2013). Communication skills training for breast cancer teams talking about trials. The Breast. 23(2). 193–197. 22 indexed citations
8.
Simcock, Richard, Lesley Fallowfield, Kathryn Monson, et al.. (2012). ARIX: A randomised trial of acupuncture v oral care sessions in patients with chronic xerostomia following treatment of head and neck cancer. Annals of Oncology. 24(3). 776–783. 72 indexed citations
9.
Fallowfield, Lesley, Lucy Kilburn, C. Langridge, et al.. (2012). Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation. British Journal of Cancer. 106(6). 1062–1067. 39 indexed citations
10.
Catt, Susan, C. Langridge, Lesley Fallowfield, Denis Talbot, & Valerie Jenkins. (2011). Reasons given by patients for participating, or not, in Phase 1 cancer trials. European Journal of Cancer. 47(10). 1490–1497. 55 indexed citations
11.
Jenkins, Valerie, Ivonne Solis‐Trapala, C. Langridge, et al.. (2010). What Oncologists Believe They Said and What Patients Believe They Heard: An Analysis of Phase I Trial Discussions. Journal of Clinical Oncology. 29(1). 61–68. 105 indexed citations
12.
Fallowfield, Lesley, Justin Stebbing, Jeremy Braybrooke, C. Langridge, & Valerie Jenkins. (2010). The preferences and experiences of different bisphosphonate treatments in women with breast cancer. Psycho-Oncology. 20(7). 755–761. 11 indexed citations
13.
Jenkins, Valerie, Daniel Farewell, Tim Maughan, et al.. (2010). The attitudes of 1066 patients with cancer towards participation in randomised clinical trials. British Journal of Cancer. 103(12). 1801–1807. 63 indexed citations
14.
Dixon, J. Michael, Lorna Renshaw, C. Langridge, et al.. (2010). Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability. Breast Cancer Research and Treatment. 125(3). 741–749. 14 indexed citations
15.
Catt, Susan, Lesley Fallowfield, & C. Langridge. (2006). What non-prescription treatments do UK women with breast cancer use?. European Journal of Cancer Care. 15(3). 279–285. 18 indexed citations
16.
Fallowfield, Lesley, Lou Atkins, Susan Catt, et al.. (2005). Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer. Annals of Oncology. 17(2). 205–210. 143 indexed citations
17.
Fleissig, Anne, Lesley Fallowfield, C. Langridge, et al.. (2005). Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Research and Treatment. 95(3). 279–293. 376 indexed citations
18.
Catt, Susan, Lesley Fallowfield, Valerie Jenkins, C. Langridge, & Anna Cox. (2005). The informational roles and psychological health of members of 10 oncology multidisciplinary teams in the UK. British Journal of Cancer. 93(10). 1092–1097. 73 indexed citations
19.
Jenkins, Valerie, Lesley Fallowfield, Ivonne Solis‐Trapala, C. Langridge, & Vernon T. Farewell. (2005). Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme. BMJ. 330(7488). 400–400. 72 indexed citations
20.
Cox, Anna, Valerie Jenkins, Susan Catt, C. Langridge, & Lesley Fallowfield. (2005). Information needs and experiences: An audit of UK cancer patients. European Journal of Oncology Nursing. 10(4). 263–272. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026